Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1075 of 3173 entries
View as:

Drug-Drug Interaction Study to Estimate the Effect of PF-07321332/Ritonavir and Ritonavir on Midazolam in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05032950 Org: User:
Start: 09/17/21 End: 12/09/21 Due: 12/09/22

A Multiple Dose Trial Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-04457845 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00836082 Org: User:
Start: 02/28/09 End: 07/31/09 Due: 07/31/10

A Study to Understand What the Body Does to the Study Medicine Called PF-07220060 When Taken by Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT06267963 Org: User:
Start: 01/31/24 End: 04/12/24 Due: 04/12/25

A 14-Month Study On The Effects Of CP-945,598 For The Prevention Of Weight Regain In Obese Patients

Phase: N/A Priority: Normal
NCT ID: NCT00483171 Org: User:
Start: 01/31/08 End: 01/31/09 Due: 01/31/10

Azithromycin Plus Chloroquine Versus Mefloquine for the Treatment of Uncomplicated Malaria in Africa

Phase: N/A Priority: Normal
NCT ID: NCT00082576 Org: User:
Start: 06/30/04 End: 05/31/06 Due: 05/31/07

Validation of Molecular Diagnostic Thecnologies for Lung Cancer Patients.

Phase: N/A Priority: Normal
NCT ID: NCT03220230 Org: User:
Start: 07/06/15 End: 10/30/18 Due: 10/30/19

A Study to Evaluate GBT021601-012 Single Dose and Multiple Dose in Participants With Sickle Cell Disease (SCD)

Phase: N/A Priority: Normal
NCT ID: NCT04983264 Org: User:
Start: 05/21/21 End: 12/06/22 Due: 12/06/23

A Study to Learn About the Vaccine RSVpreF In Pregnant Participants With HIV and Their Infants

Phase: N/A Priority: Normal
NCT ID: NCT06325657 Org: User:
Start: 03/12/24 End: 06/05/25 Due: 06/05/26

A Study Of The Safety, Tolerability, And Pharmacokinetics Of Multiple Doses Of PF-05180999 In Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT01981486 Org: User:
Start: 06/30/14 End: 01/31/15 Due: 01/31/16

Pharmacoeconomic Analysis of First Line Meropenem Versus Standard Antibiotic Treatment in Seriously Infected Secondary Nosocomial Sepsis Syndrome Patients.

Phase: N/A Priority: Normal
NCT ID: NCT00318552 Org: User:
Start: 01/31/02 End: 06/30/06 Due: 06/30/07

Safety and Efficacy Study of Subjects With Onychomycosis of the Great Toenail

Phase: N/A Priority: Normal
NCT ID: NCT00679523 Org: User:
Start: 11/30/05 End: 02/28/07 Due: 02/28/08

Phase 1 Study To Evaluate Antiviral Activity Of Small Molecule Direct Antiviral Agent At Multiple Doses In Subjects With Chronically Infected Hepatitis C Virus.

Phase: N/A Priority: Normal
NCT ID: NCT00671671 Org: User:
Start: 04/30/08 End: 12/31/08 Due: 12/31/09

Study of Pregnancy Outcomes in Women Exposed to Rimegepant During Pregnancy

Phase: N/A Priority: Normal
NCT ID: NCT05198245 Org: User:
Start: 12/15/21 End: 04/17/28 Due: 04/17/29

A DOSE-RANGING STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-06700841 IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

Phase: N/A Priority: Normal
NCT ID: NCT03845517 Org: User:
Start: 04/18/19 End: 10/05/23 Due: 10/05/24

A Clinical Trial Comparing Short-Term Efficacy and Safety of Exubera and Lantus

Phase: N/A Priority: Normal
NCT ID: NCT00367445 Org: User:
Start: 09/30/06 End: 02/28/07 Due: 02/28/08

MagnetisMM-4: Umbrella Study of Elranatamab (PF-06863135) in Combination With Anti-Cancer Treatments in Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT05090566 Org: User:
Start: 10/27/21 End: 10/23/27 Due: 10/23/28

Safety And Efficacy Of Irinotecan Plus Capecitabine As First-Line Treatment In Asian Subjects With Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00635323 Org: User:
Start: 11/30/02 End: 05/31/05 Due: 05/31/06

Study Evaluating the Efficacy and Safety of Etanercept and Acitretin in Korean Patient With Moderate to Severe Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00936065 Org: User:
Start: 07/31/09 End: 04/30/11 Due: 04/30/12

A Bioequivalence Study Comparing Methylprednisolone Suspension to Methylprednisolone Tablets Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01405170 Org: User:
Start: 10/14/11 End: 02/20/12 Due: 02/20/13

Oral Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adult Japanese Participants (ELEVATE UC 40 JAPAN)

Phase: N/A Priority: Normal
NCT ID: NCT04706793 Org: User:
Start: 12/25/20 End: 08/03/22 Due: 08/03/23

EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease

Phase: N/A Priority: Normal
NCT ID: NCT05261139 Org: User:
Start: 03/07/22 End: 07/30/26 Due: 07/30/27

Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Psoriasis)

Phase: N/A Priority: Normal
NCT ID: NCT03885089 Org: User:
Start: 10/21/19 End: 03/08/24 Due: 03/08/25

Safety and Efficacy Trial of Zavegepant* Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen

Phase: N/A Priority: Normal
NCT ID: NCT04346615 Org: User:
Start: 04/25/20 End: 04/29/22 Due: 04/29/23

Effects Of Sitaxsentan On Proteinuria, 24-Hour Blood Pressure, And Arterial Stiffness In Chronic Kidney Disease Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00810732 Org: User:
Start: 05/09/07 End: 03/06/09 Due: 03/06/10

A Single Dose Study Of PF-05161704 In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01183715 Org: User:
Start: 07/31/10 End: 09/30/10 Due: 09/30/11